Position in OGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,334,851
+$1,295,413 QoQ
Shares Held
172,441
-0.6% QoQ
Ownership
0.066%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#109
of 626 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Thrivent Financial for Lutherans holds $1,673,064,906 across 14 Drug Manufacturers - General names. OGN ranks #10 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
396,540 | $475,622,010 | |
| 2 | JNJ |
Johnson & Johnson
|
1,458,722 | $370,471,625 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,340,397 | $300,741,013 | |
| 4 | AMGN |
Amgen Inc
|
494,025 | $178,896,331 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
876,893 | $110,786,660 | |
| 6 | ABBV |
AbbVie Inc.
|
391,576 | $98,536,182 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,147,117 | $66,096,880 | |
| 8 | AZN |
Astrazeneca PLC
|
282,337 | $53,536,741 |
All Filings in OGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,334,851 | 172,441 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,039,438 | 173,529 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $1,280,841 | 178,639 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $2,643,385 | 247,508 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $2,956,949 | 305,470 | Shares | Defined | 2025-08-26 | |
| 2025-03-31 | $2,816,696 | 189,167 | Shares | Sole | 2025-08-26 | |
| 2024-12-31 | $2,970,049 | 199,065 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $3,867,894 | 202,190 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $4,419,243 | 213,490 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $4,974,028 | 264,576 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $4,252,558 | 294,907 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $186,498 | 10,743 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $225,954 | 10,858 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $256,814 | 10,919 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $304,269 | 10,894 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $253,843 | 10,848 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $363,251 | 10,763 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $374,554 | 10,723 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $328,890 | 10,801 | Shares | Sole | 2022-02-16 | |
| 2021-09-30 | $356,591 | 10,875 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $950,587 | 31,414 | Shares | Sole | 2021-09-24 | |
| No filing history on record for this holder in this stock. | ||||||